Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
IONS has been in the news recently: Ionis Pharmaceuticals, Inc. announced topline results from its Phase 3 CORE and CORE2 studies of olezarsen, a treatment for severe hypertriglyceridemia. Meanwhile, U.S. stock markets experienced a decline on the same day, with notable movements in other companies unrelated to Ionis.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.